OR2W6P

Across TCGA pan-cancer cohorts, OR2W6P RNA is linked to patient survival in 22 of 34 cancer types, making it the most broadly survival-associated OR2W6P data layer.

The strongest signal is observed in ovarian serous cystadenocarcinoma (OV), where higher OR2W6P RNA is associated with better overall survival. In most high-consensus cancer types, elevated OR2W6P expression acts as an unfavorable survival marker, although some lineages such as OV and BLCA show a favorable association.

OV, CHOL, and BLCA are the cancer types where OR2W6P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
OV	OS	Tertile	IV	0.598	0.303	.002	82	view →
CHOL	DFS	Median	II,III,IV	0.121	0.626	.002	51	view →
BLCA	OS	Tertile	All	0.695	0.332	.001	39	view →
LGG	OS	Tertile	All	0.722	0.850	<.001	33	view →
MESO	DFS	Tertile	IV	0.073	0.381	<.001	27	view →
ESCA	DFS	Median	IV	0.205	0.634	.006	24	view →
ACC	OS	Tertile	II,III,IV	0.621	0.914	.014	21	view →
SKCM	DFS	Median	IV	0.954	0.134	.003	21	view →
LUAD	OS	Tertile	All	0.198	0.501	.003	16	view →
KIRC	DFS	Median	III,IV	0.767	0.551	.009	12	view →
LIHC	OS	Quartile	All	0.691	0.817	.014	10	view →
CESC	DFS	Median	All	0.775	0.862	.021	10	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 22 lineages.

OR2W6P–OV (OS)

Open the OV breakdown →